Stock info Arca Biopharma | Filter  Basic-Info

Stock: Arca Biopharma (US broad)

Last Price 1.78 Max Price 2.11
Min Price 1.58 1 Year return -17.21
Sector Health Care Subsector Biotechnology
Annual report 2016

Loading...

Contact info:Street: 3801 Old Greenwood RoadZip Code: AR 72903City: WestminsterCountry: USAPhone: 720-940-2200Email: bd@arcabiopharma.comWebsite: www.arcabioarma.comCFO: Mr. Bradley K. Oswald

Sector Review Arca Biopharma

Loading...
Year Turnover Total sector Market share
2019 0 141,925 0.00 %
2020 0 170,231 0.00 %
2021 0 252,886 0.00 %
2022 0 238,500 0.00 %
2023 0 0 0.00 %

Advice Arca Biopharma

No Records Found




News Arca Biopharma

No Records Found

Annual reports Arca Biopharma

2017 2018 2019 2020 2021

Profile Arca Biopharma

Arca Biopharma


The past year was a good year for Arca Biopharma investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 44 percent. Over the period 2011-2016 the stock lost a massive -66,67 percent. Arca Biopharma's net incomes between 2011 and 2015 were very volatile through the time and moved between -5,36 million dollars and -11,45 million dollars.

Arca Biopharma's head office is located in Westminster. Arca Biopharma's core business is the biotech sector. The global biotech companies gained around 59 percent over the period 2006-2016. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.

The American company didn't pay out any dividends (in the past 5 years).

Arca Biopharma financed with relatively a lot of debt

At the end of 2015 the American company had a balance sheet of 39,57 million dollars. Last year the total debt of the company was 1,5 million dollars. This equals around 3,79 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around -4. So investors paid -4 times the company's 2015's EPS. Based on the classical stock valuation theories the American stock can be seen as a value stock.

The biotech company's market capitalization (the number of shares outstanding times the market value) equaled around 29,25 million dollars. At the end of 2015 around 6,29 million stocks were listed.

All Arca Biopharma's annual reports can be found here. More information about Arca Biopharma can be found it's website. .


Results Arca Biopharma

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
Costs
11
16
18
8
5
10
Profit
-11
-16
-18
-8
-5
-10
Margin of profit
0.0
0.0
0.0
0.0
0.0
ROI
-30.08
-74.09
-179.86
-131.51
-72.01
-20.94

Balance Arca Biopharma

Balance
2015
2016
2017
2018
2019
2020
Equity
38
22
10
6
8
47
Debt
2
2
2
1
1
4
Total assets
40
25
12
7
9
50
Solvency
96.21
90.09
83.10
88.29
89.11
92.25
Cash
39
21
12
7
8
49
Cashflow
-11
-15
-17
-8
-5
-8
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-7.02
-6.14
-8.36
-10.30
-5.16
-1.98

Details Arca Biopharma

Details
2016
2017
2018
2019
2020
Price
83.70
51.30
24.30
6.00
5.71
Eps
-32.64
-31.91
-10.31
-4.15
-2.07
Price/earnings-ratio
-2.56
-1.61
-2.36
-1.45
-0.86
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
43.98
15.71
7.80
4.77
4.87
Market to book
0.53
0.31
0.32
0.80
2.74
Cashflow per stock
-29.71
-26.71
-10.65
-3.01
-0.81
Stocks
1
1
1
2
10
Market Cap
42.23
33.56
18.80
9.56
17.00

Dividend Arca Biopharma


Price info Arca Biopharma

Date
Price
22 Mar 2024
1.78
18 Mar 2024
1.69
15 Mar 2024
1.70
12 Mar 2024
1.65
11 Mar 2024
1.64
09 Mar 2024
1.64
07 Mar 2024
1.66
01 Mar 2024
1.65
29 Feb 2024
1.67
27 Feb 2024
1.65
22 Feb 2024
1.63
21 Feb 2024
1.64
20 Feb 2024
1.67
15 Feb 2024
1.64
14 Feb 2024
1.60
13 Feb 2024
1.66
09 Feb 2024
1.65
08 Feb 2024
1.60
07 Feb 2024
1.59
06 Feb 2024
1.60
05 Feb 2024
1.62
01 Feb 2024
1.59
31 Jan 2024
1.64
30 Jan 2024
1.70
27 Jan 2024
1.69
25 Jan 2024
1.59
24 Jan 2024
1.58
23 Jan 2024
1.61
16 Jan 2024
1.63
11 Jan 2024
1.68